VALIDATED EXECUTIVE ENGAGEMENTS
POOL + OUTREACH
3669
Number of executives repeatedly engaged by snail & email outreach
INTERACTIONS
662
Interactions with Platform & by Email
PARTICIPANTS
112
Unique # Participated
VALIDATIONS
51
Responses Validated*
* Login to view program details and full enterprise executive list.
DATE
JUL 2020
TABLES
104
PAGES
175
EDITION
7
PRICE
USD $4950
The World of Drug Discovery Informatics is Changing Fast!
It's Time to Identify Upcoming Revenue Pockets & Growth Areas.
Amid the COVID-19 crisis, the global market for Drug Discovery Informatics estimated at US$2 Billion in the year 2020, is projected to reach a revised size of US$3.8 Billion by 2027, growing at a CAGR of 9.8% over the analysis period 2020-2027. Sequencing & Target Data Analysis, one of the segments analyzed in the report, is projected to record a 11.5% CAGR and reach US$1.2 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Docking segment is readjusted to a revised 8.3% CAGR for the next 7-year period.
The Drug Discovery Informatics market in the U.S. is estimated at US$591.8 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$657.8 Million by the year 2027 trailing a CAGR of 9.1% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 9% and 8% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 8% CAGR.
In the global Molecular Modelling segment, USA, Canada, Japan, China and Europe will drive the 10.4% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$329.5 Million in the year 2020 will reach a projected size of US$657.8 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$441.1 Million by the year 2027.We bring years of research experience to this 7th edition of our report. The 175-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.
Certara USA, Inc.; Charles River Laboratories International, Inc.; Collaborative Drug Discovery, Inc.; Dassault Systemes; GVK Biosciences Pvt., Ltd.; IBM Corporation; Infosys Ltd.; Jubilant Life Sciences Ltd.; Novo Informatics Pvt., Ltd.; Openeye Scientific Software; PerkinElmer, Inc.; Schrodinger LLC; Selvita SA; Thermo Fisher Scientific, Inc.
» End-Use (Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROS), Other End-Uses) » Function (Sequencing & Target Data Analysis, Docking, Molecular Modelling, Library Preparation, Other Functions) » Solution (Software, Services)
» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World
INSIDER ACCESS PRIVILEGES
Users of our portal have insider access to our data stacks based on project relevance and engagement status. Tiered access is offered to data stacks, managed based on user status - Opt-in, Active Panelist, Inactive Panelist, Active Client or Inactive Client.
KEY DIFFERENTIATORS
We are firmly committed to build upon perspectives from global executive insights. These engagements enrich our projects. Our primary research programs are fully validated and accessible by clients. (Its a common industry-wide* practice that no validated primary research is done! For the most part, remote resident analysts curate and write reports drawing on search engine research and data modeling.
* A review of 262 off-the-shelf market report publishers worldwide.
WHAT SETS US APART
Client companies can access multiple features on our MarketGlass™ platform.
Clients have full-stack insider access to our ongoing primary research program. We have a very successful incentive driven primary research program that benefits participating executives regardless of their purchase decision. Our platform presents a unique opportunity to collaborate with peers and review competitors’ inputs and response clusters.
Detailed engagement stats are presented for every company and executive contacted. This is made available for our client reviews. (no other publisher offers this!)
A full-stack access to clients of all primary and secondary source content. This can often run into thousands of pages.
Where relevent and possible we present competitive brands.
Peer-to-peer online interactive collaborations. Allows for team curated bespoke analytics.
Customers can update and build bespoke versions of our analytics. Bespoke updates are fulfilled within a two-day turnaround.
Discretely bounce off queries to participant pool of executives. Our embedded AI selectively pings participants geographically and by domain acumen.
We pride in our commitment to provide support to our clients. We go beyond the scope of the study to get you timely answers.
Unlike the industry’s published PDF’s that are frozen in time from date of release, our research programs are ongoing and dynamic. Our reports are updated whenever there’s a major event impacting the marketplace. Your license offers seamless updates for one year.
All updates are offered for one year from date of your purchase without charge. Clients can opt for annual auto renewal and stay current without interruption.
05
| I. INTRODUCTION, METHODOLOGY & REPORT SCOPE |
| II. EXECUTIVE SUMMARY |
| 1. MARKET OVERVIEW |
| Drug Discovery Informatics: A Prelude |
| Global Competitor Market Shares |
| Drug Discovery Informatics Competitor Market Share Scenario Worldwide (in %): 2019 & 2025 |
| Impact of Covid-19 and a Looming Global Recession |
| 2. FOCUS ON SELECT PLAYERS |
| 3. MARKET TRENDS & DRIVERS |
| Robust Drug Discovery Investments in Response to Growing Global Disease Burden Provides the Foundation for Growth in the Market |
| Growing Global Disease Burden Intensifies the R&D Urgency for New & Potent Drugs: Global Disease Burden (In Million DALYs (Disability-Adjusted Life Years)) for the Years 2015, 2017 & 2019 |
| Rising Drug Development Spending Acts as the Chief Catalyst for the Adoption of Drug Discovery Informatics: Global Pharmaceutical R&D Spending (In US$ Billion) for the Years 2017, 2019, 2022 and 2024 |
| Migration to Data Driven Drug Development Provides the Cornerstone for Growth in the Market |
| Growing Focus on Optimizing Hit to Lead (H2L) Processes in Early Stage Drug Discovery to Benefit Growth of Drug Discovery Informatics/Chemoinformatics |
| Growing Use of In-Silico Methods in Drug Development Bodes Well for the Use of Informatics |
| The Rise of Nanoinformatics as the New Era of Research in Nanomedicine Marks the Beginning of Use of Informatics in Nanomedicine |
| Exploding Commercial Opportunity for Nanomedicine Bodes Well for the Growth of Nanoinformatics: Global Nanomedicine Market (In US$ Billion) for the Years 2017, 2019, 2022 and 2024 |
| Cloud Computing Emerges to Play a Key Role in Bioinformatics |
| Cost Benefits Over In-House Informatics Helps Expand the Commercial Visibility of Outsourced Informatics |
| Continuously Evolving CRO Industry Highlights the Growing Importance & Value of Pharma R&D Outsourcing: Global Contract Research Organization (CRO) Market (In US$ Billion) for the Years 2017, 2019, 2022 and 2024 |
| Robust Adoption of Bioinformatics Services Highlights the Growing Dominance of Informatics Outsourcing Over Traditional In-House Informatics: Global Bioinformatics Services Market (In US$ Billion) by Service Type for the Years 2017, 2019, 2022 and 2024 |
| Competitive Challenges Faced by the Pharma Industry & the Ensuing Need for Decision Support Tools & Collaborative Discovery Opens the Flood Gates of Opportunity for Drug Discovery Informatics |
| Rising Global Healthcare Spending Spurs Government Focus On Cost Containment Driving Pharma Companies to Cut Drug Prices by Reducing Research Costs: Global Healthcare Spending (In US$ Trillion) by Government, Private & Consumer Out-of-Pocket for the Years 2017, 2019, 2022 and 2025 |
| Productivity Gains, Acceleration of Speed & Success of Drug Discovery Research Drive Adoption of Drug Discovery Informatics |
| Move Towards Value-Based Care & the Resulting Emergence of the Era of Precision Medicine Catalyzes the Commercial Value of Drug Discovery Informatics |
| Robust Outlook for Precision Medicine Strengthens the Business Case for Drug Discovery Informatics: Global Market for Precision Medicine (In US$ Billion) for the Years 2017, 2019, 2022 and 2024 |
| 4. GLOBAL MARKET PERSPECTIVE |
| Drug Discovery Informatics Global Market Estimates and Forecasts in US$ Thousand by Region/Country: 2020-2027 |
| Drug Discovery Informatics Market Share Shift across Key Geographies Worldwide: 2020 VS 2027 |
| Sequencing & Target Data Analysis (Function) World Market by Region/Country in US$ Thousand: 2020 to 2027 |
| Sequencing & Target Data Analysis (Function) Market Share Breakdown of Worldwide Sales by Region/Country: 2020 VS 2027 |
| Docking (Function) Potential Growth Markets Worldwide in US$ Thousand: 2020 to 2027 |
| Docking (Function) Market Sales Breakdown by Region/Country in Percentage: 2020 VS 2027 |
| Molecular Modelling (Function) Geographic Market Spread Worldwide in US$ Thousand: 2020 to 2027 |
| Molecular Modelling (Function) Market Share Distribution in Percentage by Region/Country: 2020 VS 2027 |
| Library Preparation (Function) World Market Estimates and Forecasts by Region/Country in US$ Thousand: 2020 to 2027 |
| Library Preparation (Function) Market Share Breakdown by Region/Country: 2020 VS 2027 |
| Other Functions (Function) World Market by Region/Country in US$ Thousand: 2020 to 2027 |
| Other Functions (Function) Market Share Distribution in Percentage by Region/Country: 2020 VS 2027 |
| Software (Solution) World Market Estimates and Forecasts in US$ Thousand by Region/Country: 2020 to 2027 |
| Software (Solution) Market Percentage Share Distribution by Region/Country: 2020 VS 2027 |
| Services (Solution) Market Opportunity Analysis Worldwide in US$ Thousand by Region/Country: 2020 to 2027 |
| Services (Solution) Market Share Distribution in Percentage by Region/Country: 2020 VS 2027 |
| Pharmaceutical & Biotechnology Companies (End-Use) Worldwide Sales in US$ Thousand by Region/Country: 2020-2027 |
| Pharmaceutical & Biotechnology Companies (End-Use) Market Share Shift across Key Geographies: 2020 VS 2027 |
| Contract Research Organizations (CROS) (End-Use) Global Market Estimates & Forecasts in US$ Thousand by Region/Country: 2020-2027 |
| Contract Research Organizations (CROS) (End-Use) Market Share Breakdown by Region/Country: 2020 VS 2027 |
| Other End-Uses (End-Use) Demand Potential Worldwide in US$ Thousand by Region/Country: 2020-2027 |
| Other End-Uses (End-Use) Share Breakdown Review by Region/Country: 2020 VS 2027 |
| III. MARKET ANALYSIS |
| GEOGRAPHIC MARKET ANALYSIS |
| UNITED STATES |
| Market Facts & Figures |
| US Drug Discovery Informatics Market Share (in %) by Company: 2019 & 2025 |
| Dwindling Government Funding Support for Healthcare R&D, A Major Challenge for Growth in the Country |
| United States Drug Discovery Informatics Market Estimates and Projections in US$ Thousand by Function: 2020 to 2027 |
| United States Drug Discovery Informatics Market Share Breakdown by Function: 2020 VS 2027 |
| United States Drug Discovery Informatics Market Estimates and Projections in US$ Thousand by Solution: 2020 to 2027 |
| United States Drug Discovery Informatics Market Share Breakdown by Solution: 2020 VS 2027 |
| United States Drug Discovery Informatics Latent Demand Forecasts in US$ Thousand by End-Use: 2020 to 2027 |
| Drug Discovery Informatics Market Share Breakdown in the United States by End-Use: 2020 VS 2027 |
| CANADA |
| Canadian Drug Discovery Informatics Market Estimates and Forecasts in US$ Thousand by Function: 2020 to 2027 |
| Drug Discovery Informatics Market in Canada: Percentage Share Breakdown of Sales by Function for 2020 and 2027 |
| Canadian Drug Discovery Informatics Market Estimates and Forecasts in US$ Thousand by Solution: 2020 to 2027 |
| Drug Discovery Informatics Market in Canada: Percentage Share Breakdown of Sales by Solution for 2020 and 2027 |
| Canadian Drug Discovery Informatics Market Quantitative Demand Analysis in US$ Thousand by End-Use: 2020 to 2027 |
| Canadian Drug Discovery Informatics Market Share Analysis by End-Use: 2020 VS 2027 |
| JAPAN |
| Japanese Market for Drug Discovery Informatics: Annual Sales Estimates and Projections in US$ Thousand by Function for the Period 2020-2027 |
| Japanese Drug Discovery Informatics Market Share Analysis by Function: 2020 VS 2027 |
| Japanese Market for Drug Discovery Informatics: Annual Sales Estimates and Projections in US$ Thousand by Solution for the Period 2020-2027 |
| Japanese Drug Discovery Informatics Market Share Analysis by Solution: 2020 VS 2027 |
| Japanese Demand Estimates and Forecasts for Drug Discovery Informatics in US$ Thousand by End-Use: 2020 to 2027 |
| Drug Discovery Informatics Market Share Shift in Japan by End-Use: 2020 VS 2027 |
| CHINA |
| Chinese Drug Discovery Informatics Market Growth Prospects in US$ Thousand by Function for the Period 2020-2027 |
| Chinese Drug Discovery Informatics Market by Function: Percentage Breakdown of Sales for 2020 and 2027 |
| Chinese Drug Discovery Informatics Market Growth Prospects in US$ Thousand by Solution for the Period 2020-2027 |
| Chinese Drug Discovery Informatics Market by Solution: Percentage Breakdown of Sales for 2020 and 2027 |
| Chinese Demand for Drug Discovery Informatics in US$ Thousand by End-Use: 2020 to 2027 |
| Chinese Drug Discovery Informatics Market Share Breakdown by End-Use: 2020 VS 2027 |
| EUROPE |
| Market Facts & Figures |
| European Drug Discovery Informatics Market: Competitor Market Share Scenario (in %) for 2019 & 2025 |
| European Drug Discovery Informatics Market Demand Scenario in US$ Thousand by Region/Country: 2018-2025 |
| European Drug Discovery Informatics Market Share Shift by Region/Country: 2020 VS 2027 |
| European Drug Discovery Informatics Market Estimates and Forecasts in US$ Thousand by Function: 2020-2027 |
| European Drug Discovery Informatics Market Share Breakdown by Function: 2020 VS 2027 |
| European Drug Discovery Informatics Market Estimates and Forecasts in US$ Thousand by Solution: 2020-2027 |
| European Drug Discovery Informatics Market Share Breakdown by Solution: 2020 VS 2027 |
| European Drug Discovery Informatics Addressable Market Opportunity in US$ Thousand by End-Use: 2020-2027 |
| European Drug Discovery Informatics Market Share Analysis by End-Use: 2020 VS 2027 |
| FRANCE |
| Drug Discovery Informatics Market in France by Function: Estimates and Projections in US$ Thousand for the Period 2020-2027 |
| French Drug Discovery Informatics Market Share Analysis by Function: 2020 VS 2027 |
| Drug Discovery Informatics Market in France by Solution: Estimates and Projections in US$ Thousand for the Period 2020-2027 |
| French Drug Discovery Informatics Market Share Analysis by Solution: 2020 VS 2027 |
| Drug Discovery Informatics Quantitative Demand Analysis in France in US$ Thousand by End-Use: 2020-2027 |
| French Drug Discovery Informatics Market Share Analysis: A 7-Year Perspective by End-Use for 2020 and 2027 |
| GERMANY |
| Drug Discovery Informatics Market in Germany: Recent Past, Current and Future Analysis in US$ Thousand by Function for the Period 2020-2027 |
| German Drug Discovery Informatics Market Share Breakdown by Function: 2020 VS 2027 |
| Drug Discovery Informatics Market in Germany: Recent Past, Current and Future Analysis in US$ Thousand by Solution for the Period 2020-2027 |
| German Drug Discovery Informatics Market Share Breakdown by Solution: 2020 VS 2027 |
| Drug Discovery Informatics Market in Germany: Annual Sales Estimates and Forecasts in US$ Thousand by End-Use for the Period 2020-2027 |
| Drug Discovery Informatics Market Share Distribution in Germany by End-Use: 2020 VS 2027 |
| ITALY |
| Italian Drug Discovery Informatics Market Growth Prospects in US$ Thousand by Function for the Period 2020-2027 |
| Italian Drug Discovery Informatics Market by Function: Percentage Breakdown of Sales for 2020 and 2027 |
| Italian Drug Discovery Informatics Market Growth Prospects in US$ Thousand by Solution for the Period 2020-2027 |
| Italian Drug Discovery Informatics Market by Solution: Percentage Breakdown of Sales for 2020 and 2027 |
| Italian Demand for Drug Discovery Informatics in US$ Thousand by End-Use: 2020 to 2027 |
| Italian Drug Discovery Informatics Market Share Breakdown by End-Use: 2020 VS 2027 |
| UNITED KINGDOM |
| United Kingdom Market for Drug Discovery Informatics: Annual Sales Estimates and Projections in US$ Thousand by Function for the Period 2020-2027 |
| United Kingdom Drug Discovery Informatics Market Share Analysis by Function: 2020 VS 2027 |
| United Kingdom Market for Drug Discovery Informatics: Annual Sales Estimates and Projections in US$ Thousand by Solution for the Period 2020-2027 |
| United Kingdom Drug Discovery Informatics Market Share Analysis by Solution: 2020 VS 2027 |
| United Kingdom Demand Estimates and Forecasts for Drug Discovery Informatics in US$ Thousand by End-Use: 2020 to 2027 |
| Drug Discovery Informatics Market Share Shift in the United Kingdom by End-Use: 2020 VS 2027 |
| REST OF EUROPE |
| Rest of Europe Drug Discovery Informatics Market Estimates and Forecasts in US$ Thousand by Function: 2020-2027 |
| Rest of Europe Drug Discovery Informatics Market Share Breakdown by Function: 2020 VS 2027 |
| Rest of Europe Drug Discovery Informatics Market Estimates and Forecasts in US$ Thousand by Solution: 2020-2027 |
| Rest of Europe Drug Discovery Informatics Market Share Breakdown by Solution: 2020 VS 2027 |
| Rest of Europe Drug Discovery Informatics Addressable Market Opportunity in US$ Thousand by End-Use: 2020-2027 |
| Rest of Europe Drug Discovery Informatics Market Share Analysis by End-Use: 2020 VS 2027 |
| ASIA-PACIFIC |
| Drug Discovery Informatics Market in Asia-Pacific by Function: Estimates and Projections in US$ Thousand for the Period 2020-2027 |
| Asia-Pacific Drug Discovery Informatics Market Share Analysis by Function: 2020 VS 2027 |
| Drug Discovery Informatics Market in Asia-Pacific by Solution: Estimates and Projections in US$ Thousand for the Period 2020-2027 |
| Asia-Pacific Drug Discovery Informatics Market Share Analysis by Solution: 2020 VS 2027 |
| Drug Discovery Informatics Quantitative Demand Analysis in Asia-Pacific in US$ Thousand by End-Use: 2020-2027 |
| Asia-Pacific Drug Discovery Informatics Market Share Analysis: A 7-Year Perspective by End-Use for 2020 and 2027 |
| REST OF WORLD |
| Rest of World Drug Discovery Informatics Market Estimates and Forecasts in US$ Thousand by Function: 2020 to 2027 |
| Drug Discovery Informatics Market in Rest of World: Percentage Share Breakdown of Sales by Function for 2020 and 2027 |
| Rest of World Drug Discovery Informatics Market Estimates and Forecasts in US$ Thousand by Solution: 2020 to 2027 |
| Drug Discovery Informatics Market in Rest of World: Percentage Share Breakdown of Sales by Solution for 2020 and 2027 |
| Rest of World Drug Discovery Informatics Market Quantitative Demand Analysis in US$ Thousand by End-Use: 2020 to 2027 |
| Rest of World Drug Discovery Informatics Market Share Analysis by End-Use: 2020 VS 2027 |
| IV. COMPETITION |
| Total Companies Profiled : 41 Click here to request a full table of contents and more details on this project. |
| V. CURATED RESEARCH |
INSIDER ACCESS TO
METHODOLOGY
QUESTIONNAIRE
INFLUENCER NETWORK
Registration is required to access our data stacks.
RESEARCH PANEL
Panelists are carefully chosen based on their domain expertise and market influence.
Participation in our expert panels is only by invitation. Our project focused panels are constituted of senior executives in business strategy, marketing, sales, and product management at competitive companies worldwide. We also welcome individuals from leading management consulting, venture capital, private equity, investment management and related firms with domain expertise and are actively monitoring specific companies or industries. Our panelists bring unique market perspectives and unbiased intelligence to our ongoing research programs.
Our panelists give 30-minutes a month or a one-time 30-minute participation based on their time and willingness.
- Complimentary previews of full stack research data for participated
- Insider access to research programs including engagements and stats from other panelists
- Unlimited research credits of $1000 per participated project
- Competitive Intelligence Alerts including engagements from other panelists and validated participants worldwide relevant to your company
- Interact with other panelists via our MarketGlassTM Data Exchange Platform*
- BlogX - Panelists can use our blogging platform publish their viewpoints on news relevant to their domain expertise. Platform enables panelists to share their viewpoints on current news and events related to their areas domain expertise with timely and insightful blogs*
* Complete details will be shared with panelists upon formal acceptance.
Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.
What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com